Jun 24, 2020 6:30am EDT ProMIS Neurosciences announces adjournment and change of location of annual meeting of shareholders
Jun 17, 2020 6:30am EDT ProMIS Neurosciences and collaborator BC Neuroimmunology announce significant progress on development of highly accurate antibody test for COVID-19
May 28, 2020 6:30am EDT ProMIS Neurosciences and collaborative team receive Supercluster Award supporting avoidance of future pandemics by new strains of the COVID-19 virus
May 20, 2020 6:30am EDT ProMIS Neurosciences Chairman’s Update details new programs from expanded use of novel technology platform
May 19, 2020 6:30am EDT ProMIS Neurosciences and BC Neuroimmunology expand collaboration to develop and commercialize proprietary diagnostic assays
May 12, 2020 6:30am EDT ProMIS Neurosciences identifies multiple novel targets on SARS CoV-2 for development of a highly accurate COVID-19 antibody test
May 06, 2020 6:30am EDT ProMIS Neurosciences develops novel antagonists for RACK1, a protein involved in numerous neurodegenerative diseases, including ALS
Apr 30, 2020 6:30am EDT ProMIS Neurosciences creates novel intrabodies for ALS, frontotemporal dementia and other neurodegenerative diseases
Apr 22, 2020 2:43pm EDT ProMIS Neurosciences commends Biogen for clarifying aducanumab regulatory filing